Huili Sun Selected Research

Artemether

3/2022	Combined treatment with niclosamide ethanolamine and artemether combination improves type 1 diabetes via the targeting of liver mitochondria.
1/2022	Artemether Alleviates Diabetic Kidney Disease by Modulating Amino Acid Metabolism.
1/2022	Combination therapy with artemether and enalapril improves type 1 diabetic nephropathy through enhancing antioxidant defense.
1/2021	Artemether ameliorates kidney injury by restoring redox imbalance and improving mitochondrial function in Adriamycin nephropathy in mice.
1/2019	Artemether improves type 1 diabetic kidney disease by regulating mitochondrial function.
1/2019	Artemether ameliorates type 2 diabetic kidney disease by increasing mitochondrial pyruvate carrier content in db/db mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huili Sun Research Topics

Disease

11	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 04/2013
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2022 - 01/2016
6	Neoplasms (Cancer) 10/2019 - 05/2014
5	Hypertrophy 01/2022 - 01/2018
4	Body Weight (Weight, Body) 01/2020 - 01/2013
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 01/2016
3	Wounds and Injuries (Trauma) 01/2022 - 01/2013
3	Kidney Diseases (Kidney Disease) 01/2022 - 01/2019
3	Inflammation (Inflammations) 01/2020 - 04/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2018
2	Mucositis 03/2021 - 04/2018
2	Malnutrition (Nutritional Deficiencies) 03/2021 - 01/2016
2	Muscular Atrophy (Muscle Atrophy) 01/2021 - 01/2018
2	Fibrosis (Cirrhosis) 01/2020 - 04/2013
2	Hyperglycemia 01/2019 - 01/2019
2	beta-Thalassemia (Cooley's Anemia) 05/2012 - 08/2011
1	Starvation 01/2021
1	Tauopathies 01/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020
1	Lupus Nephritis 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Amyloidosis 01/2020
1	Atrophy 01/2020
1	Ischemic Stroke 03/2019
1	Malaria 01/2019
1	Hereditary Nephritis (Alport Syndrome) 01/2019
1	Albuminuria 07/2018
1	Glioma (Gliomas) 01/2018
1	Fibroadenoma 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Proteinuria 04/2013
1	Neonatal Jaundice 05/2012
1	Jaundice (Icterus) 05/2012
1	Glucosephosphate Dehydrogenase Deficiency 05/2012

Drug/Important Bio-Agent (IBA)

6	Artemether FDA Link 03/2022 - 01/2019
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2013
6	AlbuminsIBA 01/2020 - 01/2018
5	Niclosamide FDA Link 03/2022 - 01/2018
5	Ethanolamine (Colamine)IBA 03/2022 - 01/2018
4	Polysaccharides (Glycans)IBA 03/2021 - 01/2016
4	Streptozocin (Streptozotocin)FDA Link 01/2021 - 04/2013
4	SaltsIBA 01/2021 - 01/2018
4	astragaloside AIBA 01/2020 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
2	Blood Glucose (Blood Sugar)IBA 03/2022 - 07/2018
2	Insulin (Novolin)FDA Link 01/2021 - 01/2019
2	Therapeutic UsesIBA 01/2021 - 04/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2020
2	Biological ProductsIBA 01/2021 - 01/2020
2	CollagenIBA 01/2019 - 04/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 01/2019
2	Fluorouracil (Carac)FDA LinkGeneric 04/2018 - 01/2016
2	renalaseIBA 01/2018 - 01/2013
1	Enalapril FDA LinkGeneric 01/2022
1	Amino Acids FDA Link 01/2022
1	AntioxidantsIBA 01/2022
1	Autophagy-Related ProteinsIBA 01/2021
1	triheptanoinIBA 01/2020
1	LipidsIBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Nanoparticle Drug Delivery SystemIBA 10/2019
1	Pharmaceutical PreparationsIBA 10/2019
1	liposomal doxorubicin (Doxil)FDA Link 10/2019
1	Liposomes (Liposome)IBA 10/2019
1	buyang huanwuIBA 03/2019
1	Glucagon (Glukagon)FDA Link 01/2019
1	Ether (Diethyl Ether)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Serum AlbuminIBA 01/2019
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2019
1	Monocarboxylic Acid TransportersIBA 01/2019
1	artemisinin (artemisinine)IBA 01/2019
1	CreatinineIBA 07/2018
1	Lipocalin-2IBA 07/2018
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2018
1	Acetylglucosaminidase (NAGase)IBA 07/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Protons (Proton)IBA 01/2018
1	MicellesIBA 01/2018
1	Estrogen ReceptorsIBA 01/2018
1	Mitogen-Activated Protein Kinase 3IBA 01/2018
1	ResveratrolIBA 01/2018
1	UbiquitinIBA 01/2018
1	Caspase 3 (Caspase-3)IBA 01/2018
1	Amyloid beta-PeptidesIBA 01/2016
1	Huang QiIBA 01/2016
1	LigandsIBA 09/2014
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2014
1	calcium phosphateIBA 05/2014
1	DNA (Deoxyribonucleic Acid)IBA 05/2014
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2013
1	Matrix Metalloproteinases (MMPs)IBA 04/2013
1	Perindopril FDA LinkGeneric 04/2013
1	lumbrokinaseIBA 04/2013
1	BilirubinIBA 05/2012

Therapy/Procedure

8	Therapeutics 01/2022 - 05/2014
3	Drug Therapy (Chemotherapy) 03/2021 - 01/2016
1	Intraperitoneal Injections 01/2021
1	Lasers (Laser) 01/2018